We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy
Proteins are an important class of biological macromolecules composed of amino acids present in living organisms. They play a variety of important roles, including participating in the metabolism, transportation, and transmission of nerve impulses in the body in organisms, and they are important molecules necessary to maintain life activities. Peptides are proteins of low molecular weight, usually consisting of less than 50 amino acid residues. Similar to proteins, peptides also play various important biological roles.
Ace Therapeutics offers hundreds of natural and recombinant proteins & peptides for stroke research, including but not limited to, cytokines, neuroprotective proteins, apoptotic factors, and inflammatory mediators.
Importantly, each of our products is verified by standard quality control procedures and tested for biological activity and low endotoxicity.
Please access our all-series proteins & peptides or contact our scientist for personalized assistance.
| Cat.# | Name | Size | Description | Price |
|---|---|---|---|---|
| ACPP-1346 | GFAP Blocking Peptide (AC1346) | 250 µg |
GFAP Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1347 | Human HDL Protein (AC1347) | 10 mg |
High Density Lipoprotein Human
|
inquiry |
| ACPP-1348 | Presenilin 1 Blocking Peptide (AC1348) | 250 µg |
Presenilin 1 Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1349 | Estrogen Receptor alpha Blocking Peptide (AC1349) | 250 µg |
Estrogen Receptor alpha Blocking Peptide for Immunocompetition, Immunodepletion
|
inquiry |
| ACPP-1350 | Presenilin 2 Blocking Peptide (AC1350) | 250 µg |
Presenilin 2 Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1351 | Dopamine D2 Receptor Blocking Peptide (AC1351) | 250 µg |
Dopamine D2 Receptor Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1352 | Myocilin Blocking Peptide (AC1352) | 250 µg |
Myocilin Blocking Peptide for Immunocompetition, Immunodepletion
|
inquiry |
| ACPP-1353 | PDE7B Blocking Peptide (AC1353) | 250 µg |
PDE7B Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1354 | PAX2 Blocking Peptide (AC1354) | 250 µg |
PAX2 Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1355 | MERTK Blocking Peptide (AC1355) | 250 µg |
MERTK Blocking Peptide for Immunocompetition, Immunodepletion
|
inquiry |
| ACPP-1356 | GIRK2 Blocking Peptide (AC1356) | 250 µg |
GIRK2 Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1357 | P2Y12 Blocking Peptide (AC1357) | 250 µg |
P2Y12 Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1358 | CRMP3 Blocking Peptide (AC1358) | 250 µg |
CRMP3 Blocking Peptide for Immunocompetition, Immunodepletion
|
inquiry |
| ACPP-1359 | iNOS Blocking Peptide (AC1359) | 250 µg |
iNOS Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1360 | Human GAD65 Protein (AC1360) | 1 mg |
Human GAD65 Protein for
|
inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.